Citation Impact
Citing Papers
Public Policy and the Challenge of Chronic Noncommunicable Diseases
2007
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Reducing HPV-Associated Cancer Globally
2012
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
2010
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
2004
Human papillomavirus and cervical cancer
2013
Chapter 17: Second generation HPV vaccines to prevent cervical cancer
2006
In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
2010
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
2012 Standout
Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies
2005
Detection of human papillomavirus type 18 E6 and E7‐specific CD4+ T‐helper 1 immunity in relation to health versus disease
2005
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
2010
Cancer statistics, 2013
2013 Standout
Cervical Coinfection with Human Papillomavirus (HPV) Types and Possible Implications for the Prevention of Cervical Cancer by HPV Vaccines
2005
Papillomaviruses—to vaccination and beyond
2008 StandoutNobel
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
2009
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
2006
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Structure of Dengue Virus
2002 Standout
Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
2011
The molecular biology of head and neck cancer
2010 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
2009
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
2007
Global cancer statistics
2011 Standout
Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region
2006
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Human papillomavirus and cervical cancer
2007 Standout
Chapter 2: The burden of HPV-related cancers
2006
Cancer statistics, 2012
2012 Standout
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
A multimeric L2 vaccine for prevention of animal papillomavirus infections
2011
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Chapter 1: HPV in the etiology of human cancer
2006
Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico
2010
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
2011 Standout
Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo
2007
Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
2006
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
2006
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
2005
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
2007 Standout
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
2009
Human papillomavirus infection and the primary and secondary prevention of cervical cancer
2008
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
2008
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Cervical cancer
2019 Standout
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
2008
A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
2011
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
2009
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Optimal Drug Cocktail Design: Methods for Targeting Molecular Ensembles and Insights from Theoretical Model Systems
2008
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
2009
Molecular biology of human papillomavirus infection and cervical cancer
2006
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Human Parvovirus B19
2002 Standout
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
2005
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
2007
Human Papillomavirus and Cervical Cancer
2003 Standout
Oral human papillomavirus infection in men who have sex with men with anal squamous intraepithelial lesions
2015
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2
2007
Cancer statistics, 2014
2014 Standout
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
2008
Global cancer statistics, 2012
2015 Standout
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Works of Doudja Hammouda being referenced
Against which human papillomavirus types shall we vaccinate and screen? the international perspective
2004
Cervical carcinoma in Algiers, Algeria: Human papillomavirus and lifestyle risk factors
2004
Human papillomavirus infection in a population‐based sample of women in Algiers, Algeria
2010